Literature DB >> 17153250

[Cognition on demand?--The wish for cognition-enhancing drugs in medicine].

Matthis Synofzik1.   

Abstract

DEFINITION OF THE PROBLEM: Due to recent advances in psychopharmacology, a large variety of drugs can be offered that intend to improve one's mood, memory and executive functions. These offers seem to meet the wishes and needs of people striving for enhancement of their mental capacities. How should medicine deal with these wishes? And, especially, what criteria might serve a physician's decision-making? ARGUMENTS: As shown in the following, this decision-making process cannot be convincingly informed by criteria drawing on the distinction between 'enhancement' and 'treatment' or on certain concepts of disease, normality or medicine. Instead, a decision-making model will be developed which builds on the traditional criteria of a physician's practice: the criteria of benevolence, non-maleficence, and autonomy.
CONCLUSION: By means of this model, a new concept of "medicine-on-demand" will be suggested: a subjective medicine with a physician's recommendation and veto right.

Entities:  

Keywords:  Analytical Approach; Health Care and Public Health

Mesh:

Substances:

Year:  2006        PMID: 17153250     DOI: 10.1007/s00481-006-0412-3

Source DB:  PubMed          Journal:  Ethik Med        ISSN: 0935-7335            Impact factor:   0.474


  11 in total

1.  Mild cognitive impairment: clinical characterization and outcome.

Authors:  R C Petersen; G E Smith; S C Waring; R J Ivnik; E G Tangalos; E Kokmen
Journal:  Arch Neurol       Date:  1999-03

2.  [Conclusions from the Viagra case? Definition of disease in social legislation as exemplified by erectile dysfunction].

Authors:  M H Werner; U Wiesing
Journal:  Gesundheitswesen       Date:  2002-07

3.  AD2000: donepezil in Alzheimer's disease.

Authors:  Lon S Schneider
Journal:  Lancet       Date:  2004-06-26       Impact factor: 79.321

Review 4.  Four models of the physician-patient relationship.

Authors:  E J Emanuel; L L Emanuel
Journal:  JAMA       Date:  1992 Apr 22-29       Impact factor: 56.272

5.  Another data/rhetoric mismatch on donepezil.

Authors:  Thomas E Finucane
Journal:  J Am Geriatr Soc       Date:  2005-10       Impact factor: 5.562

Review 6.  The run on Ritalin. Attention deficit disorder and stimulant treatment in the 1990s.

Authors:  L H Diller
Journal:  Hastings Cent Rep       Date:  1996 Mar-Apr       Impact factor: 2.683

7.  Do we need a concept of disease?

Authors:  G Hesslow
Journal:  Theor Med       Date:  1993-03

8.  Determining "medical necessity" in mental health practice.

Authors:  J E Sabin; N Daniels
Journal:  Hastings Cent Rep       Date:  1994 Nov-Dec       Impact factor: 2.683

Review 9.  Selective serotonin reuptake inhibitors in childhood depression: systematic review of published versus unpublished data.

Authors:  Craig J Whittington; Tim Kendall; Peter Fonagy; David Cottrell; Andrew Cotgrove; Ellen Boddington
Journal:  Lancet       Date:  2004-04-24       Impact factor: 79.321

Review 10.  Serotonin and depression: a disconnect between the advertisements and the scientific literature.

Authors:  Jeffrey R Lacasse; Jonathan Leo
Journal:  PLoS Med       Date:  2005-11-08       Impact factor: 11.069

View more
  1 in total

1.  True to oneself? Broad and narrow ideas on authenticity in the enhancement debate.

Authors:  L L E Bolt
Journal:  Theor Med Bioeth       Date:  2007-10-02
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.